Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza A

Identifieur interne : 005911 ( Main/Exploration ); précédent : 005910; suivant : 005912

Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza A

Auteurs : Catherine Moore [Royaume-Uni] ; Sam Hibbitts [Royaume-Uni] ; Neil Owen [Royaume-Uni] ; Sally A. Corden [Royaume-Uni] ; Graham Harrison [Royaume-Uni] ; Julie Fox [Canada] ; Colin Gelder [Royaume-Uni] ; Diana Westmoreland [Royaume-Uni]

Source :

RBID : ISTEX:D902DC75E4F16B690006F9B83531F51DC6B244EB

English descriptors

Abstract

The development and introduction of effective treatment for influenza A in the form of neuraminidase inhibitors have made the rapid diagnosis of infection important especially in high‐risk populations. The aim of this study was to develop a real‐time nucleic acid sequenced based amplification (NASBA) using a molecular beacon that could detect a wide range of influenza A subtypes and strains in a single reaction by targeting a conserved region of the influenza genome, and to evaluate its sensitivity and specificity against traditional laboratory techniques on a range of clinical samples usefulness during the 2003/2004 influenza season. The results demonstrated the assay to be highly sensitive and specific, detecting <0.1 TCID50 of virus stock. Three hundred eighty‐nine clinical samples were tested in total from two patient groups. Overall, the real‐time NASBA assay detected 64% (66/103) more influenza positive samples than cell culture and direct immunofluorescence (IF) and, therefore, was shown to be more sensitive in detecting influenza A in a wide range of respiratory samples than traditional methods. In conclusion, the real‐time influenza A assay demonstrated clinical usefulness in both hospital and community populations. J. Med. Virol. 74:619–628, 2004. © 2004 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jmv.20221


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza A</title>
<author>
<name sortKey="Moore, Catherine" sort="Moore, Catherine" uniqKey="Moore C" first="Catherine" last="Moore">Catherine Moore</name>
</author>
<author>
<name sortKey="Hibbitts, Sam" sort="Hibbitts, Sam" uniqKey="Hibbitts S" first="Sam" last="Hibbitts">Sam Hibbitts</name>
</author>
<author>
<name sortKey="Owen, Neil" sort="Owen, Neil" uniqKey="Owen N" first="Neil" last="Owen">Neil Owen</name>
</author>
<author>
<name sortKey="Corden, Sally A" sort="Corden, Sally A" uniqKey="Corden S" first="Sally A." last="Corden">Sally A. Corden</name>
</author>
<author>
<name sortKey="Harrison, Graham" sort="Harrison, Graham" uniqKey="Harrison G" first="Graham" last="Harrison">Graham Harrison</name>
</author>
<author>
<name sortKey="Fox, Julie" sort="Fox, Julie" uniqKey="Fox J" first="Julie" last="Fox">Julie Fox</name>
</author>
<author>
<name sortKey="Gelder, Colin" sort="Gelder, Colin" uniqKey="Gelder C" first="Colin" last="Gelder">Colin Gelder</name>
</author>
<author>
<name sortKey="Westmoreland, Diana" sort="Westmoreland, Diana" uniqKey="Westmoreland D" first="Diana" last="Westmoreland">Diana Westmoreland</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D902DC75E4F16B690006F9B83531F51DC6B244EB</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/jmv.20221</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-QMWKGM1W-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001240</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001240</idno>
<idno type="wicri:Area/Istex/Curation">001240</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F90</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F90</idno>
<idno type="wicri:doubleKey">0146-6615:2004:Moore C:development:and:evaluation</idno>
<idno type="wicri:Area/Main/Merge">005D57</idno>
<idno type="wicri:Area/Main/Curation">005911</idno>
<idno type="wicri:Area/Main/Exploration">005911</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza A</title>
<author>
<name sortKey="Moore, Catherine" sort="Moore, Catherine" uniqKey="Moore C" first="Catherine" last="Moore">Catherine Moore</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Wales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff</wicri:regionArea>
<wicri:noRegion>Cardiff</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Correspondence address: Wales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff, CF14 4XW</wicri:regionArea>
<wicri:noRegion>CF14 4XW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hibbitts, Sam" sort="Hibbitts, Sam" uniqKey="Hibbitts S" first="Sam" last="Hibbitts">Sam Hibbitts</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Obstetrics and Gynaecology, UWCM, Cardiff</wicri:regionArea>
<wicri:noRegion>Cardiff</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Owen, Neil" sort="Owen, Neil" uniqKey="Owen N" first="Neil" last="Owen">Neil Owen</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Wales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff</wicri:regionArea>
<wicri:noRegion>Cardiff</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Corden, Sally A" sort="Corden, Sally A" uniqKey="Corden S" first="Sally A." last="Corden">Sally A. Corden</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Wales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff</wicri:regionArea>
<wicri:noRegion>Cardiff</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Harrison, Graham" sort="Harrison, Graham" uniqKey="Harrison G" first="Graham" last="Harrison">Graham Harrison</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>NPHS Microbiology Carmarthenshire, West Wales General Hospital, Carmarthen</wicri:regionArea>
<wicri:noRegion>Carmarthen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fox, Julie" sort="Fox, Julie" uniqKey="Fox J" first="Julie" last="Fox">Julie Fox</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Infectious Diseases, University of Calgary and Molecular Diagnostics, Provincial Laboratory for Public Health, Calgary, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gelder, Colin" sort="Gelder, Colin" uniqKey="Gelder C" first="Colin" last="Gelder">Colin Gelder</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Llandough Hospital, Penarth</wicri:regionArea>
<wicri:noRegion>Penarth</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Westmoreland, Diana" sort="Westmoreland, Diana" uniqKey="Westmoreland D" first="Diana" last="Westmoreland">Diana Westmoreland</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Wales Specialist Virology Centre, NPHS Microbiology Cardiff, University Hospital of Wales, Cardiff</wicri:regionArea>
<wicri:noRegion>Cardiff</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Medical Virology</title>
<title level="j" type="alt">JOURNAL OF MEDICAL VIROLOGY</title>
<idno type="ISSN">0146-6615</idno>
<idno type="eISSN">1096-9071</idno>
<imprint>
<biblScope unit="vol">74</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="619">619</biblScope>
<biblScope unit="page" to="628">628</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-12">2004-12</date>
</imprint>
<idno type="ISSN">0146-6615</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0146-6615</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody titer</term>
<term>Assay</term>
<term>Assay evaluation</term>
<term>Beacon</term>
<term>Catherine moore</term>
<term>Cell culture</term>
<term>Cell suspension</term>
<term>Clin</term>
<term>Clinical excellence</term>
<term>Clinical samples</term>
<term>Community populations</term>
<term>Convalescent</term>
<term>Convalescent sample</term>
<term>Copy number</term>
<term>Detection rate</term>
<term>Elli</term>
<term>Example results</term>
<term>Genetic shift</term>
<term>Hibbitts</term>
<term>Internal control</term>
<term>Kappa statistic</term>
<term>Lysis buffer</term>
<term>Microbiol</term>
<term>Molecular assays</term>
<term>Molecular beacon</term>
<term>Molecular techniques</term>
<term>Monoclonal antibodies</term>
<term>More methods</term>
<term>Nasba</term>
<term>Nasba assay</term>
<term>Nasba assays</term>
<term>Nasba detection</term>
<term>Nasba reaction</term>
<term>Nasba results</term>
<term>Nasba testing</term>
<term>Nasopharyngeal aspirates</term>
<term>National institute</term>
<term>Negative control signal</term>
<term>Negative result</term>
<term>Negative samples</term>
<term>Neuraminidase</term>
<term>Neuraminidase genes</term>
<term>Neuraminidase inhibitors</term>
<term>Nphs microbiology cardiff</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleic acid sequence</term>
<term>Nursing home</term>
<term>Optical density</term>
<term>Oseltamivir</term>
<term>Oseltamivir treatment</term>
<term>Outbreak</term>
<term>Patient group</term>
<term>Positive result</term>
<term>Positive samples</term>
<term>Post mortem tissue samples</term>
<term>Primary care centers</term>
<term>Primer</term>
<term>Prototype strains</term>
<term>Rapid diagnosis</term>
<term>Reaction volume</term>
<term>Respiratory samples</term>
<term>Respiratory swabs</term>
<term>Respiratory viruses</term>
<term>Sampling rate</term>
<term>Serial dilutions</term>
<term>Serology</term>
<term>Severe illness</term>
<term>Sigmoid curve</term>
<term>Simple method</term>
<term>Single reaction</term>
<term>Swab</term>
<term>Throat swabs</term>
<term>Total population</term>
<term>Traditional laboratory techniques</term>
<term>Traditional methods</term>
<term>University hospital</term>
<term>Uorescence signal</term>
<term>Virol</term>
<term>Virus</term>
<term>Virus input</term>
<term>Virus stock</term>
<term>Wales specialist virology centre</term>
<term>Welsh assembly government</term>
<term>Wide range</term>
<term>Zambon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The development and introduction of effective treatment for influenza A in the form of neuraminidase inhibitors have made the rapid diagnosis of infection important especially in high‐risk populations. The aim of this study was to develop a real‐time nucleic acid sequenced based amplification (NASBA) using a molecular beacon that could detect a wide range of influenza A subtypes and strains in a single reaction by targeting a conserved region of the influenza genome, and to evaluate its sensitivity and specificity against traditional laboratory techniques on a range of clinical samples usefulness during the 2003/2004 influenza season. The results demonstrated the assay to be highly sensitive and specific, detecting <0.1 TCID50 of virus stock. Three hundred eighty‐nine clinical samples were tested in total from two patient groups. Overall, the real‐time NASBA assay detected 64% (66/103) more influenza positive samples than cell culture and direct immunofluorescence (IF) and, therefore, was shown to be more sensitive in detecting influenza A in a wide range of respiratory samples than traditional methods. In conclusion, the real‐time influenza A assay demonstrated clinical usefulness in both hospital and community populations. J. Med. Virol. 74:619–628, 2004. © 2004 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Moore, Catherine" sort="Moore, Catherine" uniqKey="Moore C" first="Catherine" last="Moore">Catherine Moore</name>
</noRegion>
<name sortKey="Corden, Sally A" sort="Corden, Sally A" uniqKey="Corden S" first="Sally A." last="Corden">Sally A. Corden</name>
<name sortKey="Gelder, Colin" sort="Gelder, Colin" uniqKey="Gelder C" first="Colin" last="Gelder">Colin Gelder</name>
<name sortKey="Harrison, Graham" sort="Harrison, Graham" uniqKey="Harrison G" first="Graham" last="Harrison">Graham Harrison</name>
<name sortKey="Hibbitts, Sam" sort="Hibbitts, Sam" uniqKey="Hibbitts S" first="Sam" last="Hibbitts">Sam Hibbitts</name>
<name sortKey="Moore, Catherine" sort="Moore, Catherine" uniqKey="Moore C" first="Catherine" last="Moore">Catherine Moore</name>
<name sortKey="Moore, Catherine" sort="Moore, Catherine" uniqKey="Moore C" first="Catherine" last="Moore">Catherine Moore</name>
<name sortKey="Owen, Neil" sort="Owen, Neil" uniqKey="Owen N" first="Neil" last="Owen">Neil Owen</name>
<name sortKey="Westmoreland, Diana" sort="Westmoreland, Diana" uniqKey="Westmoreland D" first="Diana" last="Westmoreland">Diana Westmoreland</name>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Fox, Julie" sort="Fox, Julie" uniqKey="Fox J" first="Julie" last="Fox">Julie Fox</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005911 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005911 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D902DC75E4F16B690006F9B83531F51DC6B244EB
   |texte=   Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza A
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021